# Bioavailability of Seven Mitopure Formulations

> **NCT06853197** · NA · COMPLETED · sponsor: **Amazentis SA** · enrollment: 84 (actual)

## Conditions studied

- Healthy Adults

## Interventions

- **DIETARY_SUPPLEMENT:** Mitopure (Urolithin A)

## Key facts

- **NCT ID:** NCT06853197
- **Lead sponsor:** Amazentis SA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-03-17
- **Primary completion:** 2025-05-05
- **Final completion:** 2025-05-05
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2025-05-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06853197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06853197, "Bioavailability of Seven Mitopure Formulations". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT06853197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*